Impact of antiretroviral therapy interruption on plasma biomarkers of cardiovascular risk and lipids: 144‐week final data from the <scp>STOPAR</scp> study - Concepedia

Concepedia

Publication | Closed Access

Impact of antiretroviral therapy interruption on plasma biomarkers of cardiovascular risk and lipids: 144‐week final data from the <scp>STOPAR</scp> study

11

Citations

22

References

2012

Year

Montserrat Olmo, María Saumoy, Carlos Alonso‐Villaverde, María Luz Pintos Peñaranda, Félix Gutiérrez, Joan Romeu, María Larrousse, Jordi Curto, Peré Domingo, Antonia Vila,

Abstract

A significant increase in cardiovascular risk biomarkers persisting over the prolonged study period was seen in the TI arm. This factor may contribute to the increased cardiovascular risk observed in previous studies.

References

	Year	Citations

Page 1